Akaal Pharma is a clinical-stage drug discovery and development Australian biopharmaceutical company. We are developing treatment of pruritus and inflammatory skin diseases as topical drugs. Akaal’s oral drug development is focused on neuropathy/pain and autoimmune skin diseases. Akaal Pharma multimodal action products are safe and efficacious in human patients with atopic dermatitis and psoriasis.
Akaal Pharma applies its proprietary medicinal chemistry and drug discovery platform coupled with broad and in-depth drug discovery and development expertise of leadership team to search innovative, First-in-Class, technologies. Akaal Pharma has strong portfolio of patents on its internally discovered drug candidates and is continue building and strengthening the intellectual property.
